Analyst stock forecast
BridgeBio Pharma Stock Forecast and Analyst Price Target
BBIO analyst target range, upside, consensus rating and coverage count.
Direct answer
BridgeBio Pharma's average price target is $106.19.
The target implies +29.4% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $80.00 to $157.00, with 21 analysts in the current consensus when available.
Forecast evidence checked August 5, 2026.
Verified data
- Current price
- $82.07
- Average price target
- $106.19
- High price target
- $157.00
- Low price target
- $80.00
- Target upside
- +29.4%
- Consensus rating
- Strong Buy
- Analysts
- 21
- Evidence date
- August 5, 2026
- Valid through
- August 12, 2026